Article Information
Published By
Online ISSN
History
- Received November 16, 2021
- Accepted August 1, 2022
- Published online October 13, 2022.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Gary P. Anderson1⇑,
- Louis B. Irving2,
- Andrew Jarnicki1,
- Katherine Kedzierska3,
- Marios Koutsakos3,
- Stephen Kent4,5,
- Aeron C. Hurt6,10,
- Adam K. Wheatley7,
- Thi H. O. Nguyen7,
- Natale Snape8 and
- John W. Upham9
- 1Lung Health Research Centre, Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, Victoria, Australia
- 2Department of Respiratory Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia
- 3Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia
- 4Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity and ARC Centre for Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Parkville
- 5Melbourne Sexual Health Clinic and Infectious Diseases Department, Alfred Hospital, Monash University Central Clinical School, Carlton, Victoria, Australia
- 6WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Victoria, Australia*
- 7Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Victoria, Australia
- 8Faculty of Medicine, The University of Queensland Diamantina Institute, Translational Research Institute, Queensland, Australia
- 9Faculty of Medicine, The University of Queensland Diamantina Institute, Translational Research Institute and Princess Alexandra Hospital, Queensland, Australia
- 10Present address of Dr Hurt. Department of Infectious Diseases, Roche Pharma Research & Early Development, Basel, Switzerland
- Corresponding author: Gary Anderson (gpa{at}unimelb.edu.au)
Funding
National Health and Medical Research Council
APP1081433
Article usage
Altmetrics
Vol 9 Issue 1
Table of Contents
Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study
